Annual Total Expenses
$28.88 M
+$15.86 M+121.80%
December 31, 2023
Summary
- As of March 6, 2025, SBFM annual total expenses is $28.88 million, with the most recent change of +$15.86 million (+121.80%) on December 31, 2023.
- During the last 3 years, SBFM annual total expenses has risen by +$28.23 million (+4354.43%).
- SBFM annual total expenses is now at all-time high.
Performance
SBFM Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$9.54 M
-$1.03 M-9.74%
September 30, 2024
Summary
- As of March 6, 2025, SBFM quarterly total expenses is $9.54 million, with the most recent change of -$1.03 million (-9.74%) on September 30, 2024.
- Over the past year, SBFM quarterly total expenses has stayed the same.
- SBFM quarterly total expenses is now -9.74% below its all-time high of $10.57 million, reached on June 30, 2024.
Performance
SBFM Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
SBFM Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +121.8% | 0.0% |
| 3 y3 years | +4354.4% | 0.0% |
| 5 y5 years | +2380.3% | 0.0% |
SBFM Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +982.1% | -9.7% | +1027.7% |
| 5 y | 5-year | at high | +4354.4% | -9.7% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -9.7% | >+9999.0% |
Sunshine Biopharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.54 M(-9.7%) |
| Jun 2024 | - | $10.57 M(+18.9%) |
| Mar 2024 | - | $8.89 M(+0.3%) |
| Dec 2023 | $28.88 M(+121.8%) | $8.87 M(+31.6%) |
| Sep 2023 | - | $6.74 M(+2.5%) |
| Jun 2023 | - | $6.57 M(-2.2%) |
| Mar 2023 | - | $6.72 M(-25.1%) |
| Dec 2022 | $13.02 M(+387.9%) | $8.98 M(+385.0%) |
| Sep 2022 | - | $1.85 M(+118.7%) |
| Jun 2022 | - | $846.10 K(-37.1%) |
| Mar 2022 | - | $1.35 M(+269.1%) |
| Dec 2021 | $2.67 M(+311.6%) | - |
| Dec 2021 | - | $364.70 K(-33.3%) |
| Sep 2021 | - | $546.60 K(+23.8%) |
| Jun 2021 | - | $441.50 K(-66.4%) |
| Mar 2021 | - | $1.32 M(+254.3%) |
| Dec 2020 | $648.30 K(-2.2%) | $371.30 K(+339.9%) |
| Sep 2020 | - | $84.40 K(-41.3%) |
| Jun 2020 | - | $143.70 K(+194.5%) |
| Mar 2020 | - | $48.80 K(-81.3%) |
| Dec 2019 | $662.80 K(-43.1%) | $261.10 K(+24.3%) |
| Sep 2019 | - | $210.00 K(+203.5%) |
| Jun 2019 | - | $69.20 K(-43.5%) |
| Mar 2019 | - | $122.40 K(-14.8%) |
| Dec 2018 | $1.16 M(+35.8%) | $143.70 K(-50.2%) |
| Sep 2018 | - | $288.80 K(-50.2%) |
| Jun 2018 | - | $580.50 K(+125.1%) |
| Mar 2018 | - | $257.90 K(+59.0%) |
| Dec 2017 | $857.20 K(-13.7%) | $162.20 K(+42.5%) |
| Sep 2017 | - | $113.80 K(-75.9%) |
| Jun 2017 | - | $472.20 K(+333.2%) |
| Mar 2017 | - | $109.00 K(-67.6%) |
| Dec 2016 | $993.10 K | $336.10 K(+189.7%) |
| Sep 2016 | - | $116.00 K(-75.4%) |
| Jun 2016 | - | $471.30 K(+576.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $69.70 K(-60.0%) |
| Dec 2015 | $782.00 K(-55.4%) | $174.20 K(+54.0%) |
| Sep 2015 | - | $113.10 K(-69.4%) |
| Jun 2015 | - | $369.90 K(+196.4%) |
| Mar 2015 | - | $124.80 K(-59.3%) |
| Dec 2014 | $1.76 M(-9.3%) | $306.30 K(+10.4%) |
| Sep 2014 | - | $277.40 K(-63.8%) |
| Jun 2014 | - | $765.50 K(+88.6%) |
| Mar 2014 | - | $405.90 K(-40.8%) |
| Dec 2013 | $1.94 M(+174.0%) | $685.40 K(+285.7%) |
| Sep 2013 | - | $177.70 K(+16.4%) |
| Jun 2013 | - | $152.60 K(-83.5%) |
| Mar 2013 | - | $922.90 K(+390.1%) |
| Dec 2012 | $706.70 K(+27.1%) | $188.30 K(-50.0%) |
| Sep 2012 | - | $376.40 K(+266.5%) |
| Jun 2012 | - | $102.70 K(+161.3%) |
| Mar 2012 | - | $39.30 K(-89.4%) |
| Dec 2011 | $556.20 K(+3.5%) | $372.10 K(+219.7%) |
| Sep 2011 | - | $116.40 K(+605.5%) |
| Jun 2011 | - | $16.50 K(-66.5%) |
| Mar 2011 | - | $49.20 K(-88.5%) |
| Dec 2010 | $537.40 K(+437.4%) | $426.90 K(+166.1%) |
| Sep 2010 | - | $160.40 K(-89.9%) |
| Jun 2010 | - | $1.59 M(+4489.9%) |
| Mar 2010 | - | $34.60 K(+8.1%) |
| Dec 2009 | $100.00 K(+536.9%) | - |
| Oct 2009 | - | $32.00 K(+515.4%) |
| Jul 2009 | $15.70 K(-39.8%) | $5200.00(+108.0%) |
| Apr 2009 | - | $2500.00(-26.5%) |
| Jan 2009 | - | $3400.00(-26.1%) |
| Oct 2008 | - | $4600.00(+9.5%) |
| Jul 2008 | $26.10 K(+99.2%) | $4200.00(-61.1%) |
| Apr 2008 | - | $10.80 K(+369.6%) |
| Jan 2008 | - | $2300.00(-73.9%) |
| Oct 2007 | - | $8800.00 |
| Jul 2007 | $13.10 K | - |
FAQ
- What is Sunshine Biopharma annual total expenses?
- What is the all time high annual total expenses for Sunshine Biopharma?
- What is Sunshine Biopharma annual total expenses year-on-year change?
- What is Sunshine Biopharma quarterly total expenses?
- What is the all time high quarterly total expenses for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly total expenses year-on-year change?
What is Sunshine Biopharma annual total expenses?
The current annual total expenses of SBFM is $28.88 M
What is the all time high annual total expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total expenses is $28.88 M
What is Sunshine Biopharma annual total expenses year-on-year change?
Over the past year, SBFM annual total expenses has changed by +$15.86 M (+121.80%)
What is Sunshine Biopharma quarterly total expenses?
The current quarterly total expenses of SBFM is $9.54 M
What is the all time high quarterly total expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total expenses is $10.57 M
What is Sunshine Biopharma quarterly total expenses year-on-year change?
Over the past year, SBFM quarterly total expenses has changed by $0.00 (0.00%)